The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
Open accessAbstract
CD73 is overexpressed in many types of human and mouse cancers and is implicated in the control of tumor progression. However, the specific contribution from tumor or host CD73 expression to tumor growth remains unknown to date. Here, we show that host CD73 promotes tumor growth in a T cell-dependent manner and that the optimal antitumor effect of CD73 blockade requires inhibiting both tumor and host CD73. Notably, enzymatic activity of CD73 on nonhematopoietic cells limited tumor-infiltrating T cells by controlling antitumor T cell homing to tumors in multiple mouse tumor models. In contrast, CD73 on hematopoietic cells (including CD4⁺CD25⁺ Tregs) inhibited systemic antitumor T cell expansion and effector functions. Thus, CD73 on hematopoietic and nonhematopoietic cells has distinct adenosinergic effects in regulating systemic and local antitumor T cell responses. Importantly, pharmacological blockade of CD73 using its selective inhibitor or an anti-CD73 mAb inhibited tumor growth and completely restored efficacy of adoptive T cell therapy in mice. These findings suggest that both tumor and host CD73 cooperatively protect tumors from incoming antitumor T cells and show the potential of targeting CD73 as a cancer immunotherapy strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065
Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2742 · Cited by 624
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572
Extracellular adenosine triphosphate and adenosine in cancer
Stagg, J., & Smyth, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.292 · Cited by 571
Buckanovich, R. J., Facciabene, A., Kim, S., Benencia, F., Sasaroli, D., Balint, K., Katsaros, D., O'Brien-Jenkins, A., Gimotty, P. A., & Coukos, G. (2008) · Nature Medicine · doi:10.1038/nm1699 · Cited by 546
Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia
Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C., & Colgan, S. P. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040915 · Cited by 543
Self-citationPhysiological roles for ecto-5’-nucleotidase (CD73)
Colgan, S. P., Eltzschig, H. K., Eckle, T., & Thompson, L. F. (2006) · Purinergic Signalling · doi:10.1007/s11302-005-5302-5 · Cited by 500
Self-citationKobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J., & Mosmann, T. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6780 · Cited by 466
(1997) · PubMed · Cited by 433
Jin, D., Fan, J., Wang, L., Thompson, L. F., Liu, A., Daniel, B. J., Shin, T., Curiel, T. J., & Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3109 · Cited by 432
Self-citationAdenosine receptors in regulation of dendritic cell differentiation and function
Novitskiy, S. V., Ryzhov, S., Zaynagetdinov, R., Goldstein, A. E., Huang, Y., Tikhomirov, O. Y., Blackburn, M. R., Biaggioni, I., Carbone, D. P., Feoktistov, I., et al. (2008) · Blood · doi:10.1182/blood-2008-02-136325 · Cited by 430
Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047423 · Cited by 390
Eltzschig, H. K., Thompson, L. F., Karhausen, J., Cotta, R. J., Ibla, J. C., Robson, S. C., & Colgan, S. P. (2004) · Blood · doi:10.1182/blood-2004-06-2066 · Cited by 370
Self-citationEcto‐enzyme and signaling functions of lymphocyte CD 7 3
Resta, R., Yamashita, Y., & Thompson, L. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01574.x · Cited by 332
Self-citationA2B adenosine receptor dampens hypoxia-induced vascular leak
Eckle, T., Faigle, M., Grenz, A., Laucher, S., Thompson, L. F., & Eltzschig, H. K. (2008) · Blood · doi:10.1182/blood-2007-10-117044 · Cited by 302
Self-citationTumor-promoting functions of adenosine
Spychala, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00053-x · Cited by 284
Cell-surface enzymes in control of leukocyte trafficking
Salmi, M., & Jalkanen, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1705 · Cited by 281
Sun, X., Wu, Y., Gao, W., Enjyoji, K., Csizmadia, E., Müller, C. E., Murakami, T., & Robson, S. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.007 · Cited by 279
Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties
Stelzner, T. J., Weil, J. V., & O'Brien, R. F. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390122 · Cited by 251
Hoskin, D., Mader, J., Furlong, S., Conrad, D., & Blay, J. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.527 · Cited by 242
CD73: A Novel Target for Cancer Immunotherapy
Zhang, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1544 · Cited by 236
Self-citationKoszalka, P., Özüyaman, B., Huo, Y., Zernecke, A., Flögel, U., Braun, N., Buchheiser, A., Decking, U. K. M., Smith, M. L., Sévigny, J., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000144796.82787.6f · Cited by 236
Lennon, P. F., Taylor, C. T., Stahl, G. L., & Colgan, S. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1433 · Cited by 229
Eisenring, M., vom Berg, J., Kristiansen, G., Saller, E., & Becher, B. (2010) · Nature Immunology · doi:10.1038/ni.1947 · Cited by 221
Mills, J. H., Thompson, L. F., Mueller, C., Waickman, A. T., Jalkanen, S., Niemela, J., Airas, L., & Bynoe, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711175105 · Cited by 209
Self-citationMuch Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology
Ernst, P. B., Garrison, J. C., & Thompson, L. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000108 · Cited by 199
Self-citationLitzinger, M. T., Fernando, R., Curiel, T. J., Grosenbach, D. W., Schlom, J., & Palena, C. (2007) · Blood · doi:10.1182/blood-2007-06-094615 · Cited by 188
Self-citationMandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Lenzner, D. E., Jackson, E. K., Gorelik, E., Lang, S., Johnson, J. T., & Whiteside, T. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1143 · Cited by 182
Surface expression, polarization, and functional significance of CD73 in human intestinal epithelia.
Strohmeier, G. R., Lencer, W. I., Patapoff, T. W., Thompson, L. F., Carlson, S. L., Moe, S. J., Carnes, D. K., Mrsny, R. J., & Madara, J. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119447 · Cited by 178
Self-citationIFN-γ– and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
Zhang, B., Karrison, T., Rowley, D. A., & Schreiber, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33522 · Cited by 167
Self-citationAiras, L., Niemelä, J., Salmi, M., Puurunen, T., Smith, D. J., & Jalkanen, S. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.2.421 · Cited by 163
The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
Wilson, J. M., Ross, W. G., Agbai, O. N., Frazier, R., Figler, R. A., Rieger, J. M., Linden, J. M., & Ernst, P. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801279 · Cited by 158
Host A2B Adenosine Receptors Promote Carcinoma Growth
Ryzhov, S. V., Novitskiy, S. V., Carbone, D. P., Biaggioni, I., Zaynagetdinov, R., Goldstein, A. E., Dikov, M. M., & Feoktistov, I. (2008) · Neoplasia · doi:10.1593/neo.08478 · Cited by 151
CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation
Zernecke, A., Bidzhekov, K., Özüyaman, B., Fraemohs, L., Liehn, E. A., Lüscher‐Firzlaff, J., Lüscher, B., Schrader, J., & Weber, C. (2006) · Circulation · doi:10.1161/circulationaha.105.595249 · Cited by 147
Airas, L. M., Hellman, J., Salmi, M., Bono, P., Puurunen, T., Smith, D. J., & Jalkanen, S. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1603 · Cited by 147
B7-H1–Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
Lin, P.-Y., Sun, L., Thibodeaux, S. R., Ludwig, S. M., Vadlamudi, R. K., Hurez, V. J., Bahar, R., Kious, M. J., Livi, C. B., Wall, S. R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000496 · Cited by 141
Self-citationChadjichristos, C. E., Scheckenbach, K. E. L., van Veen, T. A. B., Sarieddine, M. Z. R., de Wit, C., Yang, Z., Roth, I., Bacchetta, M. D., Viswambharan, H., Foglia, B. F., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.867176 · Cited by 137
Alam, M. S., Kurtz, C. C., Rowlett, R. M., Reuter, B. K., Wiznerowicz, E. B., Das, S., Linden, J. M., Crowe, S. E., & Ernst, P. B. (2009) · The Journal of Infectious Diseases · doi:10.1086/596205 · Cited by 135
Thomson, L., Ruedi, J. M., Glass, A. A., Moldenhauer, G., Mӧller, P., Low, M. G., Klemens, M. R., Massaia, M., & Lucas, A. H. (1990) · Tissue Antigens · doi:10.1111/j.1399-0039.1990.tb01750.x · Cited by 130
Narravula, S., Lennon, P., Mueller, B. U., & Colgan, S. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5262 · Cited by 121
Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
Jackson, S. W., Hoshi, T., Wu, Y., Sun, X., Enjyoji, K., Cszimadia, E., Sundberg, C., & Robson, S. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070190 · Cited by 104
CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
Takedachi, M., Qu, D., Ebisuno, Y., Oohara, H., Joachims, M. L., McGee, S. T., Maeda, E., McEver, R. P., Tanaka, T. T., Miyasaka, M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6288 · Cited by 93
Self-citationHomeostatic Proliferation Plus Regulatory T-Cell Depletion Promotes Potent Rejection of B16 Melanoma
Kline, J. P., Brown, I. E., Zha, Y.-Y., Blank, C. U., Strickler, J. H., Wouters, H., Zhang, L., & Gajewski, T. F. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4696 · Cited by 89
Hilchey, S. P., Kobie, J. J., Cochran, M. R., Secor‐Socha, S., Wang, J.-C. E., Hyrien, O., Burack, R., Mosmann, T. R., Quataert, S. A., & Bernstein, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900475 · Cited by 87
Airas, L. M., Niemelä, J., & Jalkanen, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5411 · Cited by 84
Erratum: TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2011) · Nature reviews. Immunology · doi:10.1038/nri3029 · Cited by 60
CD73 mediates adhesion of B cells to follicular dendritic cells
Airas, L. M., & Jalkanen, S. (1996) · Blood · doi:10.1182/blood.v88.5.1755.1755 · Cited by 59
Isolation and characterization of the promoter of the human 5′-nucleotidase (CD73)-encoding gene
Hansen, K. R., Resta, R., Webb, C. F., & Thompson, L. F. (1995) · Gene · doi:10.1016/0378-1119(95)00574-9 · Cited by 57
Self-citationHasegawa, T., Bouïs, D., Liao, H., Visovatti, S., & Pinsky, D. J. (2008) · Circulation Research · doi:10.1161/circresaha.108.180059 · Cited by 55
Dalgleish, A. G. (2010) · Cited by 51
Cited by
Harnessing innate immunity in cancer therapy
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957
Combination cancer immunotherapies tailored to the tumour microenvironment
Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Targeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.86 · Cited by 840
Metadata
- Authors
- Wang, L., Fan, J., Thompson, L. F., Zhang, Y., Shin, T., Curiel, T. J., & Zhang, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-06-01
- Volume
- 121
- Issue
- 6
- Pages
- 2371-2382
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2053908301
- Cited by
- 262
- References
- 54
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.